Maciej Giefing
- Molecular Biology
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Oncology top 10%
- Immunology top 10%
- Co-authors
- Reiner SiebertRalf KüppersMartin‐Leo HansmannWolfram KlapperSylvia HartmannJosé I. Martı́n-SuberoStefan GeskInga Vater
- Topics
- RNA modifications and cancer (18 papers)Lymphoma Diagnosis and Treatment (15 papers)Cancer-related gene regulation (10 papers)
In The Last Decade
Maciej Giefing
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 631
- Cancer Research 483
- Pathology and Forensic Medicine 418
- Oncology 396
- Immunology 331
Countries citing papers authored by Maciej Giefing
This map shows the geographic impact of Maciej Giefing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Giefing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Giefing more than expected).
Fields of papers citing papers by Maciej Giefing
This network shows the impact of papers produced by Maciej Giefing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Giefing. The network helps show where Maciej Giefing may publish in the future.
Co-authorship network of co-authors of Maciej Giefing
This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Giefing. A scholar is included among the top collaborators of Maciej Giefing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Giefing. Maciej Giefing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 10 | |
| 3 | 6 | |
| 4 | 9 | |
| 5 | 38 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 9 | |
| 9 | 32 | |
| 10 | 13 | |
| 11 | 20 | |
| 12 | 29 | |
| 13 | 26 | |
| 14 | 17 | |
| 15 | 15 | |
| 16 | 25 | |
| 17 | 38 | |
| 18 | 13 | |
| 19 | Research and diagnostic potential of estimation of chromosome instability in laryngeal squamous cell carcinoma | 2 |
| 20 | Second primary tumors of head and neck: review of theories explaining their formation and the newest terminology | 0 |
About Maciej Giefing
Maciej Giefing is a scholar working on Cancer Research, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Lymphoma Diagnosis and Treatment (15 papers) and Cancer-related gene regulation (10 papers). The work is most often cited by research in Cancer Research (483 citations), Pathology and Forensic Medicine (418 citations) and Immunology (331 citations). Maciej Giefing has collaborated with scholars based in Poland, Germany and Finland. Frequent co-authors include Reiner Siebert, Ralf Küppers, Martin‐Leo Hansmann, Wolfram Klapper, Sylvia Hartmann, José I. Martı́n-Subero, Stefan Gesk, Inga Vater, Krzysztof Szyfter and Roland Schmitz. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.